| Identification | Back Directory | [Name]
2'-fluoro-5-bromo-1-beta-D-arabinofuranosylcytosine | [CAS]
69123-93-9 | [Synonyms]
5-Bromo-2’-deoxy-2’-fluoro-β-D-arabinocytidine
5-Bromo-2’-deoxy-2’-fluoro-beta-D-arabinocytidine
5-BroMo-2'-deoxy-2'-fluoro-beta-D-arabinocytidine
2'-fluoro-5-bromo-1-beta-D-arabinofuranosylcytosine
1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-broMocytosine
1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-bromocytosine
2(1H)-Pyrimidinone, 4-amino-5-bromo-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-
4-Amino-5-Bromo-1-(2-Deoxy-2-Fluoro-beta-D-Arabinofuranosyl)-2(1H)-Pyrimidinone
4-amino-5-bromo-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | [Molecular Formula]
C9H11BrFN3O4 | [MDL Number]
MFCD25542522 | [MOL File]
69123-93-9.mol | [Molecular Weight]
324.1 |
| Hazard Information | Back Directory | [Uses]
5-Bromo-2’-deoxy-2’-fluoro-beta-D-arabinocytidine is a cytidine nucleoside analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1]. | [References]
[1] Gowher H, et al. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol Ther. 2004 Nov;3(11):1062-8. DOI:10.4161/cbt.3.11.1308 |
|
| Company Name: |
T&W GROUP
|
| Tel: |
021-61551611 13296011611 |
| Website: |
www.trustwe.com/ |
|